Winship Logo

Clinical Trial Details

Back to clinical trials
Phase N/AAncillary or Correlative

EU3075-15: Novel Diagnostic Tests for Renal Cell Carcinoma

Protocol: IRB00085068

Overview

Primary Objective:

  • To determine the sensitivity, specificity, positive predictive value, negative predictive value and accuracy of two complimentary diagnostic tests for renal cell carcinoma that have been developed at Emory in the PI and co-investigators labs.
Investigators
JP
John Petros
Location
Winship Cancer Institute